Top Quality 99% Anti Estrogen Letrozole Femara Powder for Reducing Steroids Side-Effects CAS 112809-51-5
Quick Details:
Product Name: Letrozole/ Femara
CAS: 112809-51-5
MF: C17H11N5
MW: 285.3
Purity: 99.2%
Appearance: White crystalline powder
Standard: USP/BP/EP/Enterprise Standard
Usage: A nonsteroidal aromatase inhibitor structurally related to Fadrozole; Antineoplastic. For athletes and bodybuilders, Femara is a drug used to combat the estrogenic side effects of anabolic steroids water-retention, acne and gynecomastia.
Applications of Letrozole/ Femara:
Femara is a type II (non-steroidal) third generation aromatase inhibitor. It’s primarily administered to halt the progression of breast cancer in women. It is generally used as part of an aggressive treatment in post-menopausal women, to fight and reverse the spread of breast cancer after other treatments (such as Tamoxifen therapy) has failed. It’s probably the most efficient product on the market for this purpose. Letrozole is very similar in both structure and action to its AI predecessor Arimidex. In women with breast cancer, it has been shown to reduce estrogen levels by 98% or more. However, it’s use and benefits are not limited to eliminating estrogen in women.
For athletes and bodybuilders, it is a drug used to combat the estrogenic side effects of anabolic steroids water-retention, acne and gynocomastia. It will also raise testosterone levels because of the lowered estrogen in the body.
Letrozole is currently the most powerful aromatase inhibitor available. In the world of bodybuilding it is used to reduce or eliminate excess estrogen caused by the use of aromatizing steroids.
Femara is a drug used to combat the estrogenic side effects of anabolic steroids.
Letrozole/Femara Application
For pre-contest bodybuilders, Femara is almost a necessity to eliminate water retention and achieve the ripped look necessary to compete in today’s bodybuilding world. However, in my experience, it is only necessary to be used for the last 4-6 weeks, to eliminate excess estrogen and water retention. After using Femara I recommend staying away from any estrogen suppression for at least a month to try to normalize the body.
Femara is a type II (non-steroidal) third generation aromatase inhibitor. Clinically it is used to treat postmenopausal women with either estrogen receptor positive or estrogen receptor unknown breast cancer. In women with breast cancer, it has been shown to reduce estrogen levels by 98% or more .
However, it’s use and benefits are not limited to eliminating estrogen in women.
Letrozole has been used for ovarian stimulation by fertility doctors since 2001 because it has fewer side-effects than clomiphene (Clomid) and less chance of multiple gestation. A Canadian study presented at the American Society of Reproductive Medicine 2005 Conference suggested that letrozole may increase the risk of birth defects.[citation needed] A more detailed ovulation induction follow-up study found that letrozole, compared with a control group of clomiphene, had significantly lower congenital malformations and chromosomal abnormalities at an overall rate of 2.4% (1.2% major malformations) compared with clomiphene 4.8% (3.0% major malformations).
Despite this, India banned the usage of letrozole in 2011, citing potential risks to infants.In 2012, an Indian parliamentary committee said that the drug controller office colluded with letrozole’s makers to approve the drug for infertility in India and also stated that letrozole’s use for infertility was illegal worldwide; however, such off-label uses are legal in many countries such as the US and UK.
The anti-estrogen action of letrozole has been shown to be useful in pretreatment for termination of pregnancy, in combination with misoprostol. It can be used in place of mifepristone, which is expensive and unavailable in many countries.
Sales Manager